These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 16598413

  • 1. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
    Vlachoyiannopoulos PG, Beigbeder G, Dueymes M, Youinou P, Hunt JE, Krilis SA, Moutsopoulos HM.
    Autoimmunity; 1993 Dec; 16(4):245-9. PubMed ID: 8025204
    [Abstract] [Full Text] [Related]

  • 6. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M.
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [Abstract] [Full Text] [Related]

  • 7. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L, Kontic M, Djokovic A, Marisavljevic D, Ilijevski N, Stanisavljevic N, Mikovic Z, Petkovic M, Kovcin V.
    Clin Exp Rheumatol; 2013 Apr; 31(2):234-42. PubMed ID: 23306109
    [Abstract] [Full Text] [Related]

  • 8. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [Abstract] [Full Text] [Related]

  • 9. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
    Reshetnyak T, Cheldieva F, Cherkasova M, Lila A, Nasonov E.
    Int J Mol Sci; 2022 Aug 21; 23(16):. PubMed ID: 36012697
    [Abstract] [Full Text] [Related]

  • 10. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA.
    Am J Clin Pathol; 2004 Jan 21; 121(1):142-9. PubMed ID: 14750252
    [Abstract] [Full Text] [Related]

  • 11. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep 21; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 12. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
    Uludağ Ö, Çinar S, McDonnell T, Çene E, Yalçinkaya Y, Gül A, Inanç M, Artim Esen B.
    Turk J Med Sci; 2023 Sep 21; 53(5):1067-1074. PubMed ID: 38813003
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Samarkos M, Davies KA, Gordon C, Loizou S.
    Clin Rheumatol; 2006 Mar 21; 25(2):199-204. PubMed ID: 16091839
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr 21; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I.
    Rheumatol Int; 2002 Aug 21; 22(4):142-7. PubMed ID: 12172952
    [Abstract] [Full Text] [Related]

  • 18. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
    Tsutsumi A, Hayashi T, Chino Y, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T.
    Mod Rheumatol; 2006 Aug 21; 16(3):158-64. PubMed ID: 16767554
    [Abstract] [Full Text] [Related]

  • 19. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P, Podovšovnik A, Ambrožič A, Tomšič M, Hočevar A, Gašperšič N, Rotar Ž, Praprotnik S, Šemrl SS, Čučnik S.
    Clin Rheumatol; 2019 Feb 21; 38(2):371-378. PubMed ID: 30099654
    [Abstract] [Full Text] [Related]

  • 20. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A, Ruffatti A, Mattia E, Meneghel L, Tonello M, Salvan E, Pengo V, Punzi L.
    Clin Chem Lab Med; 2015 Jul 21; 53(8):1265-70. PubMed ID: 25562605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.